Stay informed with the latest updates and insights on pharmaceuticals at Med Pharma News. Explore breaking news, industry trends, research advancements, and regulatory developments shaping the pharmaceutical landscape.
Novo Holdings has announced a $100 million investment in Swiss biotech firm Asceneuron, aimed at accelerating the development of innovative treatments for neurodegenerative diseases. This strategic funding highlights the potential impact of Asceneuron’s research on the biotech industry and patient care.
Oxford University scientists have started human testing of the Marburg virus vaccine, a crucial development in the fight against one of the world’s deadliest pathogens. The vaccine aims to protect healthcare workers and vulnerable populations in regions prone to outbreaks.
